Format

Send to

Choose Destination
Ophthalmology. 2008 Aug;115(8):1297-302, 1302.e1. doi: 10.1016/j.ophtha.2008.01.006. Epub 2008 Feb 21.

Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.

Author information

1
Public Health in Ophthalmology Working Group, Dean A. McGee Eye Institute, Oklahoma City, Oklahoma, USA.

Abstract

OBJECTIVE:

To describe the successful treatment and long-term outcomes of primary ocular surface squamous neoplasia (OSSN) with topical interferon alfa-2b or surgical excision.

DESIGN:

Retrospective, comparative, interventional case series.

PARTICIPANTS:

Twenty-nine consecutive patients with OSSN never before treated.

INTERVENTION:

Patients with primary OSSN chose topical interferon alfa-2b or excision with wide surgical margins, with crossover to surgery in those interferon-treated patients whose OSSN failed to regress within 2 months after beginning therapy.

MAIN OUTCOME MEASURES:

Successful resolution of clinical disease at 2 months after topical interferon treatment and time to recurrence after either topical interferon or surgical excision.

RESULTS:

Of 29 patients with primary OSSN, 15 elected topical interferon and 14 chose surgical excision. Two patients in the interferon group subsequently underwent surgical excision for apparent lack of response to interferon. No patient in either group developed a recurrence during the study period (disease-free follow-up: interferon group, mean, 35.6 months [95% confidence interval, 21.9-49.3]; surgery group, mean, 35.6 months [22.9-48.3]).

CONCLUSIONS:

Both topical interferon alfa-2b and aggressive surgical excision appear to be effective for primary OSSN.

PMID:
18294690
DOI:
10.1016/j.ophtha.2008.01.006
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center